F.D.A. Looks to A.I. to Enhance Efficiency
Posted inArtificial Intelligence Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Federal Budget (US) Food Food and Drug Administration Health and Human Services Department Kennedy, Robert F Jr Makary, Marty Medical Devices Prasad, Vinayak K Regulation and Deregulation of Industry Trump, Donald J United States Politics and Government

F.D.A. Looks to A.I. to Enhance Efficiency

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
Four States Ask F.D.A. to Lift Special Restrictions on Abortion Pill
Posted inAbortion Abortion Drugs Attorneys General California Drugs (Pharmaceuticals) Food and Drug Administration Massachusetts Mifeprex (RU-486) New Jersey New York State Regulation and Deregulation of Industry States (US) United States United States Politics and Government your-feed-healthcare your-feed-science

Four States Ask F.D.A. to Lift Special Restrictions on Abortion Pill

The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety.
Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments
Posted inAlternative and Complementary Medicine Biotechnology and Bioengineering Clinical Trials Drugs (Pharmaceuticals) Dystonia Food and Drug Administration Health and Human Services Department Kennedy, Robert F Jr National Institutes of Health Regulation and Deregulation of Industry Stem Cells Therapy and Rehabilitation Trump, Donald J United States Politics and Government

Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments

The U.S. health secretary said people should have access to experimental therapies including unregulated stem cells. But some methods have resulted in blindness, tumors and other injuries.